An interventional study of EXERCISE and TENS in Pelvic Pain Syndrome, sponsored by Biruni University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2024-10-16.
Sponsored by Biruni University · Not applicable, Interventional, and Treatment
The aim of this study is to evaluate the effectiveness of ESWT (Extracorporeal Shock Wave Therapy) and TENS (Transcutaneous Electrical Nerve Stimulation) in individuals diagnosed with chronic pelvic pain syndrome and treated with medication. The study was organized as a randomized controlled trial. The sample size is 30 patients suffering from chronic pelvic pain syndrome.
Volunteers who are between the ages of 20-40, diagnosed with chronic pelvic pain syndrome, and who meet the inclusion criteria will be included in the study and will be randomized into 2 groups: Group I (TENS) and Group II (ESWT).
Biruni University is the lead sponsor of 179 studies on the registry; 44 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
2. Receiving drug treatment
PHYSIOTHERAPY PROGRAM PLUS TENS
Other: EXERCISE · Other: TENS
PHYSIOTHERAPY PROGRAM PLUS ESWT
Other: EXERCISE · Other: ESWT
All participants included in this group will receive Exercises
All participants included in this group will receive TENS
All participants included in this group will receive ESWT
VISUAL ANALOUGE SCALE
It evaluates pain intensity grading between 0-10. Higher score shows severe pain.
Time frame: baseline and immediately after the intervention
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)
This assesses the quality of life. The index has sub dimensions(pain, urinary symptoms, quality of life impact). The score evaluation of the pain scale is between 1 and 21 points, the score evaluation of the urination scale is between 0 and 10 points, and the score evaluation of the quality of life scale is between 0 and 12 points.
Time frame: baseline and immediately after the intervention
ALGOMETER
This evaluates pain tolerance threshold of the patients.The less score shows pain intolerance.
Time frame: baseline and immediately after the intervention
Hospital Anxiety and Depression Scale- HAD
This evaluates depresive symtoms of the patients.This scale is a self-rating scale. The scale is a 4-point Likert type scale consisting of 14 items in total, including anxiety and depression subscales (Aydemir, Güvenir, Küey, \& Kültür, 1997). 7 items in the scale are for anxiety and 7 items are for depression. Participants will be asked to mark each item considering the situation they have experienced in the last week. Each item contains four options. Options will be scored between 0-3 points. The lowest score for the anxiety and depression subscales is 0 and the highest score is 21 points.
Time frame: baseline and immediately after the intervention
Nottingham Health Profile-NHP
This evaluates quality of life of the patients. The survey consists of 6 sections. These sections are pain, emotional reactions, social isolation, physical activity, energy and sleep. It consists of 38 items in total. Each section is scored between 0-100 points. 0 will be considered the best score and 100 will be considered the worst score.
Time frame: baseline and immediately after the intervention
Digital Muscle Testing
To evaluate muscles's strenght using by Power Track. Higher cosre shows good strneght.
Time frame: baseline and immediately after the intervention
Flexibility Measurements
To measure flexibility of the muscles, manually. The amount of elasticity is measured and the result is recorded in cm.
Time frame: baseline and immediately after the intervention
ROM Assessments
To measure range of motion of the joints by using goniometer.
Time frame: baseline and immediately after the intervention
Lasegue Test
To measure flexibility of the sciatic nerve, manually.
Time frame: baseline and immediately after the intervention
Plan to share: No
Ran from Jan 2024 to primary completion in Apr 2024, 3 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.